Bioinformatics Market size worth $ 39.74 Billion, Globally, by 2030 at 16.29% CAGR: Verified Market Research®

The global bioinformatics market is expected to record large growth in the near future, owing to a rise in the need for combined data, a rise in demand for nucleic acid & protein sequencing, owing to decrease in sequencing cost and an increase in applications of proteomics & genomics.

Boonton, New Jersey, UNITED STATES

Jersey City, New Jersey, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Bioinformatics Market” By Technology (Knowledge Management Tools, Bioinformatics Platforms, Bioinformatics Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatic), and By Geography. According to Verified Market Research, the Bioinformatics Market size was valued at USD 10.22 Billion in 2021 and is projected to reach USD 39.74 Billion by 2030, growing at a CAGR of 16.29% from 2022 to 2030.

Download PDF Brochure:

Browse in-depth TOC onBioinformatics Market

202 - Pages

126 – Tables

37 – Figures

Global Bioinformatics Market Overview

The global bioinformatics market has reserves largely resulted in data and technological progressions in bioinformatics services, which, in turn, have better the quality of these services. Also, many countries are investing in their national population sequencing programs to appreciate the link between genetics and diseases. Many government bodies and private organizations across the globe are progressively investing in the field of bioinformatics.

With the initiation of advanced NGS technologies, there is a growing need for quick and accurate bioinformatics tools that can be easily functioned. Most of the scientists complicated in the experimental investigation are not bioinformaticians. Therefore, the obtainability of user-friendly tools is vital for the use of bioinformatics platforms. Many bioinformatics tools require advanced computer expertise, mostly because they lack a suitable user-friendly interface. The growing importance of these emerging economies in terms of R&D and investments from global companies is expected to provide a favorable outlook—as well as opportunities—for the growth of genomics, metabolomics, precision medicine, drug discovery, and other markets in the coming years.

Key Developments

  • In September 2021, Agilent Technologies Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD obvious artificial intelligence (AI)-driven precision pathology software in accumulation to Agilent’s portfolio of automated pathology staining solutions. With an initial focus on Europe, this agreement marks Agilent’s first entry into the increasing digital pathology market and strengthens the relationship between the two companies by further expanding the opportunity for their long-term collaboration.
  • In April 2022, Charles River and Valo Health launched Logica an artificial intelligence (AI) powered drug resolution that directly translates clients’ biological insights into optimized preclinical assets. Logica leverages Valo’s AI-powered Opal Computational Platform and Charles River’s foremost preclinical expertise, providing clients with transformed drug discovery with a single integrated contribution seamlessly translating marks to candidate nomination.

Key Players

The major players in the market are Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc., amongst others.

Verified Market Research has segmented the Global Bioinformatics Market On the basis of Technology, Application, and Geography.

  • Bioinformatics Market, By Technology
    • Knowledge Management Tools
    • Bioinformatics Platforms
    • Bioinformatics Services
  • Bioinformatics Market, By Application
    • Metabolomics
    • Molecular phylogenetics
    • Transcriptomics
    • Proteomics
    • Chemoinformatics & drug design
    • Genomics
    • Others
  • Bioinformatics Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Proteomics Market By Reagent (Protein Microarray Reagents, X-Ray Crystallography Reagents), By Instrumentation Technology (X–Ray Crystallography, Surface Plasmon Resonance), By Software And Service (Core Proteomics Services, Bioinformatics Software And Services), By Application (Clinical Diagnostics, Drug Discovery), By End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies), By Geography, Forecast, 2021-2028

Metabolomics Market By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing), By Product And Services (Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services), By Geography, Forecast, 2021-2028

Bioinformatics Services Market By Type (Sequencing Services, Differential Gene Expression Analysis, Drug Discovery Services and Others), By Application (Genomics, Metabolomics, Proteomics, Transcriptomics, Chemoinformatics And Drug Design And Other Applications), By End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, And Other End Clients), By Geography, Forecast, 2021-2028

Bioinformatics Services Market By Product (Sequencing Services, Data Analysis, Drug Discovery Services, Differential, Others), By Application (Genomics, Chemoinformatics And Drug Design, Proteomics, Transcriptomics, Metabolomics, Others) By Geography, Forecast, 2021-2028

Top 5 Healthcare IT Companies improving the healthcare facilities with a digital touch

Visualize Bioinformatics Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.